Nelson Capital Management, LLC Amgen Inc Transaction History

Nelson Capital Management, LLC

$587 Million
Q3 2024

A detailed history of Nelson Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Nelson Capital Management, LLC holds 16,799 shares of AMGN stock, worth $4.95 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

16,799

Previous 18,150 7.44%

Holding current value

$4.95 Million

Previous $5.67 Million 4.55%

% of portfolio

0.92%

Previous 1.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $417,972 - $455,800	-1,351 Reduced 7.44%	16,799 $5.41 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $132,426 - $160,932	-504 Reduced 2.7%	18,150 $5.67 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $779,991 - $941,548	2,901 Added 18.42%	18,654 $5.3 Million
Q4 2023 Jan 26, 2024	SELL	$255.7 - $288.46 $683,230 - $770,765	-2,672 Reduced 14.5%	15,753 $4.54 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $10,057 - $12,487	-46 Reduced 0.25%	18,425 $4.95 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $46,496 - $54,981	217 Added 1.19%	18,471 $4.1 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $125,765 - $153,286	557 Added 3.15%	18,254 $4.41 Million
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $3.44 Million - $4.37 Million	15,025 Added 562.31%	17,697 $4.65 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $17,303 - $19,255	-75 Reduced 2.73%	2,672 $650,000
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $8,112 - $8,975	37 Added 1.37%	2,747 $664,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $18,467 - $21,636	-87 Reduced 3.11%	2,710 $576,000
Q4 2020 Feb 17, 2021	SELL	$216.38 - $257.67 $10,602 - $12,625	-49 Reduced 1.72%	2,797 $643,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $58,662 - $65,237	-250 Reduced 8.07%	2,846 $723,000
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $72,896 - $96,680	400 Added 14.84%	3,096 $628,000
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $56,763 - $72,960	-300 Reduced 10.01%	2,696 $650,000
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $47,880 - $57,370	275 Added 10.11%	2,996 $580,000
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $8,168 - $9,575	49 Added 1.83%	2,721 $501,000
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $39,248 - $44,241	217 Added 8.84%	2,672 $508,000
Q2 2018 Jul 17, 2018	BUY	$166.05 - $186.51 $10,461 - $11,750	63 Added 2.63%	2,455 $453,000
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $121,142 - $141,570	-715 Reduced 23.01%	2,392 $408,000
Q4 2017 Jan 26, 2018	BUY	$168.79 - $188.59 $393,280 - $439,414	2,330 Added 299.87%	3,107 $540,000
Q3 2017 Nov 02, 2017	SELL	$167.29 - $191.0 $20,576 - $23,493	-123 Reduced 13.67%	777 $145,000
Q2 2017 Aug 11, 2017	BUY	N/A	900	900 $155,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson Capital Management, LLC with notifications on news.

Account

Nelson Capital Management, LLC Amgen Inc Transaction History